Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector...

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Traditional vaccine adjuvants like aluminum nanoparticles can cause adverse effects due to persistence.
• Physical adjuvants offer a safer alternative by using transient tissue stress without lasting presence.

Purpose of the Study:

• To evaluate the efficacy of intradermal ovalbumin (OVA) protein injection without adjuvants using a needle-free pyro-drive jet injector (PJI) for tumor vaccination.
• To investigate the underlying immune mechanisms, including T cell response and antigen-presenting cell uptake.

Main Methods:

• Intradermal injection of endotoxin-free OVA protein using a PJI in a tumor vaccination model.
• Analysis of OVA-specific CD8+ T cell expansion, cytotoxic activity, and antibody production.
• Assessment of dendritic cell uptake and expression of danger signals like HMGB1.

Main Results:

• PJI delivery of OVA alone significantly increased OVA-specific CD8+ T cell expansion and induced antitumor effects.
• Enhanced uptake of OVA by XCR1+ dendritic cells, known for cross-presentation, was observed.
• Increased expression of HMGB1, a danger signal induced by shear stress, was noted.

Conclusions:

• Intradermal OVA injection via PJI without adjuvants effectively stimulates CD8+ T cell-mediated antitumor immunity.
• The mechanism involves enhanced antigen uptake by XCR1+ dendritic cells and HMGB1 upregulation.
• This needle-free approach presents a promising strategy for adjuvant-free tumor vaccination.